Redox Imbalance in Cystic Fibrosis: The Multifaceted Role of Oxidative Stress
Pharmaceuticals · 24.05.2025 · 18 (6) · 784
DOI: 10.3390/ph18060784 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 24.05.2025. Verfasst von Ilaria Artusi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine (DMM), University of Padua, 35131 Padua, Italy. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione per la Ricerca sulla Fibrosi Cistica, European Union - Next-Generation EU, Italian Cystic Fibrosis Research Foundation.
Abstract (Originalsprache)
Cystic fibrosis (CF), a severe genetic disorder stemming from mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene, is characterized by a complex interplay of chronic inflammation and heightened oxidative stress, resulting in substantial patient morbidity. The diverse array of CFTR mutations, categorized into seven distinct classes based on their functional impact on the CFTR protein, presents a significant obstacle to effective therapeutic intervention. While CFTR modulator therapies offer clinical benefits, their applicability is restricted to specific mutation classes, leaving a considerable portion of the CF patient population with unmet therapeutic needs. This review provides a critical analysis of the intricate role of oxidative stress in CF, meticulously examining its origins, mechanistic pathways and downstream pathological consequences, with particular emphasis on lipid peroxidation (LPO). It elucidates the nuanced connection between LPO and inflammatory processes driven by cellular stressors such as endoplasmic reticulum dysfunction, mitochondrial impairment and persistent bacterial infections. Furthermore, it evaluates the current landscape of therapeutic proposals targeting oxidative stress, including antioxidant interventions, and explores the potential of microRNAs (miRNAs) as novel targets. This review aims to synthesize existing research to provide a comprehensive understanding of oxidative stress involvement in CF pathogenesis while critically appraising the advantages and limitations of current antioxidant therapeutic strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Medicine (DMM), University of Padua, 35131 Padua, Italy.
- Department of Pharmaceuticals and Pharmacological Sciences (DSF), University of Padua, 35131 Padua, Italy.
- Biostructures and Biosystems National Institute (INBB), 00165 Rome, Italy.
ORCID-Profile: Ilaria Artusi, Michela Rubin, Giorgio Cozza
Förderung
- Fondazione per la Ricerca sulla Fibrosi Cistica
- European Union - Next-Generation EU
- Italian Cystic Fibrosis Research Foundation
- European Union–Next-Generation EU
Zitieren
APA
Artusi, I., Rubin, M., & Cozza, G. (2025). Redox Imbalance in Cystic Fibrosis: The Multifaceted Role of Oxidative Stress. Pharmaceuticals, 18(6), 784. https://doi.org/10.3390/ph18060784
Vancouver
Artusi I, Rubin M, Cozza G. Redox Imbalance in Cystic Fibrosis: The Multifaceted Role of Oxidative Stress. Pharmaceuticals. 2025;18(6):784. doi:10.3390/ph18060784
BibTeX
@article{Artusi2025,
author = {Artusi, Ilaria and Rubin, Michela and Cozza, Giorgio},
title = {Redox Imbalance in Cystic Fibrosis: The Multifaceted Role of Oxidative Stress},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {6},
pages = {784},
doi = {10.3390/ph18060784}
}
EUVIMED